Uh Regional Hospitals
Uh Regional Hospitals was paid $2.85M by Medicaid between Jan 2018 and Jan 2022, across 77 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
CHARDON, OH 44024
Next to other General Acute Care Hospital providers in Ohio
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 22,259 | $869K | |
| 2019 | 17,946 | $763K | |
| 2020 | 11,182 | $511K | |
| 2021 | 15,239 | $673K | |
| 2022 | 604 | $30K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 6,705 | 6,476 | $750K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 8,743 | 8,584 | $491K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 16% | 3,645 | 3,474 | $445K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 3,548 | 3,272 | $406K |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.3% | 789 | 719 | $150K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.1% | 2,035 | 1,995 | $144K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.7% | 1,236 | 1,224 | $105K |
| 80053 | Comprehensive metabolic panel | 2.6% | 5,756 | 5,103 | $74K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.5% | 1,958 | 1,218 | $44K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 202 | 186 | $41K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.2% | 83 | 78 | $35K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 8,862 | 7,788 | $14K |
65 more codes
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 147 | $13K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 55 | $11K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 541 | $9K |
| 84484 | <1% | 841 | $9K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 459 | $8K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 49 | $8K |
| G0378 | Hospital observation service, per hour | <1% | 158 | $8K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 106 | $7K |
| 83605 | <1% | 640 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,390 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 1,256 | $6K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 24 | $6K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 321 | $4K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 15 | $4K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 135 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 212 | $4K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 199 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,659 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 131 | $3K |
| 62323 | <1% | 15 | $3K | |
| 82607 | <1% | 75 | $3K | |
| 73564 | <1% | 44 | $2K | |
| 87631 | <1% | 14 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 86 | $2K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,432 | $2K |
| 80061 | Lipid panel | <1% | 109 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 457 | $1K |
| 83721 | <1% | 30 | $846.86 | |
| 80076 | <1% | 58 | $625.93 | |
| 81001 | <1% | 1,193 | $556.14 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 124 | $543.79 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 392 | $478.73 |
| 83655 | <1% | 12 | $439.46 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 68 | $415.36 |
| 81003 | <1% | 823 | $377.88 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,126 | $330.81 |
| 85610 | <1% | 1,141 | $255.17 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $244.18 |
| 84439 | <1% | 15 | $168.30 | |
| 87081 | <1% | 25 | $75.02 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 934 | $74.87 |
| 82077 | <1% | 41 | $55.44 | |
| 83690 | <1% | 189 | $51.68 | |
| 80069 | <1% | 47 | $43.93 | |
| 85027 | <1% | 14 | $34.06 | |
| 81025 | <1% | 139 | $32.64 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 478 | $26.72 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 635 | $17.53 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 361 | $11.94 |
| J2704 | Injection, propofol, 10 mg | <1% | 424 | $9.44 |
| 83735 | <1% | 92 | $8.44 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 466 | $6.18 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 439 | $4.19 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 147 | $1.32 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 231 | $0.93 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 191 | $0.00 |
| 84703 | 0% | 15 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 150 | $0.00 |
| 84075 | 0% | 12 | $0.00 | |
| 82247 | 0% | 12 | $0.00 | |
| 84450 | 0% | 12 | $0.00 | |
| 82248 | 0% | 12 | $0.00 | |
| 84460 | 0% | 12 | $0.00 | |
| 84155 | 0% | 12 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.